The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
Feb. 21, 2024
Applicant:
Immunitas Therapeutics, Inc., Waltham, MA (US);
Inventors:
Alison Tisdale, Belmont, MA (US);
Uli Bialucha, Winchester, MA (US);
George Punkosdy, Belmont, MA (US);
Alexandria Fusco, Derry, NH (US);
Frano Irvine, Medford, MA (US);
Emily Rosentrater, Marlborough, MA (US);
Elizabeth Scanlon, Allston, MA (US);
Michael Battles, Lebanon, NH (US);
Assignee:
IMMUNITAS THERAPEUTICS, INC., Waltham, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 16/28 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2851 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); G01N 33/6854 (2013.01); A61K 2039/505 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); G01N 2333/70596 (2013.01); G01N 2800/52 (2013.01);
Abstract
The invention relates generally to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using such antibodies for treating disorders associated with or mediated by CD161, for example, certain cancers. In addition, the invention also relates to expression vectors and host cells for making these antibodies.